The Hamner Institutes for Health Sciences announced BioMedomics has joined The Hamner Accelerator for Translational Bioscience.
The accelerator program provides an opportunity for leaders of emerging companies to access resources at The Hamner while also partnering on research projects and grant funding.
To support companies like BioMedomics, The Hamner collaborates with the North Carolina Biotechnology Center, the Council for Entrepreneurial Development, university business schools and other entrepreneurial programs to facilitate commercialization of new technologies.
About BioMedomics
BioMedomics (Research Triangle Park) is a privately-held bioscience and medical device company developing medical diagnostics technologies targeting point-of-care personalized genetic testing for specific disease biomarkers. The product line will include reagents, assays, processing and data analysis tools.
The firm, which was started with a $25,000 Biotechnology Center loan, also received a $100,000 Phase I Small Business Innovation Research grant from the National Institutes of Health.